Fingerprint
Dive into the research topics of 'Phase II trial of sorafenib in patients with metastatic breast cancer previously exposed to anthracyclines or taxanes: North central cancer treatment group and mayo clinic trial n0336'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically